Jerri M Rook Selected Research

Jerri M Rook Research Topics

Disease

19	Schizophrenia (Dementia Praecox) 11/2023 - 12/2010
6	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 01/2014
3	Seizures (Absence Seizure) 01/2019 - 09/2013
3	Wounds and Injuries (Trauma) 06/2009 - 09/2007
2	Parkinson Disease (Parkinson's Disease) 11/2023 - 08/2021
2	Dystonia (Limb Dystonia) 11/2023 - 08/2021
2	Central Nervous System Diseases (CNS Diseases) 08/2021 - 09/2013
2	Brain Diseases (Brain Disorder) 10/2018 - 02/2015
2	Autistic Disorder (Autism) 01/2016 - 08/2015
2	Pain (Aches) 06/2009 - 09/2007
1	Triple Negative Breast Neoplasms 01/2024
1	Acidosis 01/2024
1	Alkalosis 01/2024
1	Lung Neoplasms (Lung Cancer) 01/2024
1	Neoplasms (Cancer) 01/2024
1	Pulmonary Arterial Hypertension 10/2023
1	Movement Disorders (Movement Disorder) 08/2021
1	Neurodevelopmental Disorders 01/2021
1	Syndrome (Syndromes) 01/2017
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2016
1	Cognitive Dysfunction 01/2016
1	Autism Spectrum Disorder 08/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2015
1	Psychotic Disorders (Schizoaffective Disorder) 01/2014
1	Neurogenic Inflammation 07/2008
1	Cicatrix (Scar) 07/2008
1	Pressure Ulcer (Bedsore) 09/2007
1	Burns 09/2007

Drug/Important Bio-Agent (IBA)

8	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 08/2021 - 01/2014
7	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2018 - 12/2010
4	Cholinergic Agents (Cholinergics)IBA 01/2019 - 09/2016
3	Muscarinic M4 ReceptorIBA 11/2023 - 01/2014
3	Metabotropic Glutamate 5 ReceptorIBA 03/2016 - 10/2013
3	NeuropeptidesIBA 06/2009 - 09/2007
3	Morphine (MS Contin)FDA LinkGeneric 06/2009 - 09/2007
3	Opioid Analgesics (Opioids)IBA 06/2009 - 09/2007
2	Proteins (Proteins, Gene)FDA Link 10/2018 - 01/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2016 - 08/2015
2	Substance PIBA 06/2009 - 09/2007
2	Neurokinin AIBA 06/2009 - 09/2007
2	IntraSite GelIBA 07/2008 - 09/2007
1	Polystyrenes (Polystyrene)IBA 01/2024
1	CationsIBA 01/2024
1	Durapatite (Hydroxylapatite)IBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 01/2024
1	SolutionsIBA 01/2024
1	LigandsIBA 10/2023
1	5-HT2B Serotonin ReceptorIBA 10/2023
1	Muscarinic AntagonistsIBA 08/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 08/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	metabotropic glutamate receptor 7IBA 01/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2018
1	Hydroxyl RadicalIBA 09/2018
1	Muscarinic M1 ReceptorIBA 10/2017
1	Glutamic Acid (Glutamate)FDA Link 10/2017
1	Phencyclidine (Angel Dust)IBA 10/2017
1	Antipsychotic Agents (Antipsychotics)IBA 09/2016
1	VU0410120IBA 08/2015
1	VU0409551IBA 06/2015
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2015
1	N-Methylaspartate (NMDA)IBA 05/2015
1	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2015
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2013
1	Capsaicin (Zostrix)FDA Link 06/2009
1	Analgesics (Analgesic Drugs)IBA 07/2008
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2008
1	Hematoxylin (Haematoxylon)IBA 07/2008
1	TachykininsIBA 09/2007
1	Sulfates (Sulfates, Inorganic)IBA 09/2007
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 09/2007

Therapy/Procedure

3	Therapeutics 01/2024 - 09/2007
2	Topical Administration 07/2008 - 09/2007
1	Immunotherapy 01/2024
1	Injections 01/2024
1	Drug Therapy (Chemotherapy) 03/2016
1	Analgesia 09/2007